Aju Ib Investment Co., Ltd. Xilio Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $58.4 Million
- Q3 2022
A detailed history of Aju Ib Investment Co., Ltd. transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 667,742 shares of XLO stock, worth $647,709. This represents 3.33% of its overall portfolio holdings.
Number of Shares
667,742
Previous 667,742
-0.0%
Holding current value
$647,709
Previous $1.95 Million
0.36%
% of portfolio
3.33%
Previous 3.78%
Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
34Shares Held
14MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$4.43 Million0.65% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$2.91 Million0.08% of portfolio
-
Morgan Stanley New York, NY1.52MShares$1.48 Million0.0% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.4 Million16.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$875,4550.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $26.6M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...